NasdaqGS - Nasdaq Real Time Price USD

Surgery Partners, Inc. (SGRY)

Compare
32.50 +0.24 (+0.74%)
As of 12:15 PM EDT. Market Open.
Loading Chart for SGRY
DELL
  • Previous Close 32.26
  • Open 32.79
  • Bid 32.44 x 100
  • Ask 32.51 x 100
  • Day's Range 32.41 - 33.21
  • 52 Week Range 22.05 - 36.92
  • Volume 203,222
  • Avg. Volume 1,093,230
  • Market Cap (intraday) 4.132B
  • Beta (5Y Monthly) 2.76
  • PE Ratio (TTM) --
  • EPS (TTM) -0.26
  • Earnings Date Nov 5, 2024 - Nov 11, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 39.33

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

www.surgerypartners.com

10,500

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SGRY

View More

Performance Overview: SGRY

Trailing total returns as of 9/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

SGRY
1.59%
S&P 500
20.32%

1-Year Return

SGRY
6.56%
S&P 500
32.31%

3-Year Return

SGRY
22.62%
S&P 500
28.80%

5-Year Return

SGRY
338.01%
S&P 500
92.26%

Compare To: SGRY

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SGRY

View More

Valuation Measures

Annual
As of 9/25/2024
  • Market Cap

    4.10B

  • Enterprise Value

    7.32B

  • Trailing P/E

    2.69k

  • Forward P/E

    24.27

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.41

  • Price/Book (mrq)

    2.10

  • Enterprise Value/Revenue

    2.53

  • Enterprise Value/EBITDA

    15.46

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -1.17%

  • Return on Assets (ttm)

    3.96%

  • Return on Equity (ttm)

    3.73%

  • Revenue (ttm)

    2.89B

  • Net Income Avi to Common (ttm)

    -33.8M

  • Diluted EPS (ttm)

    -0.26

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    253.7M

  • Total Debt/Equity (mrq)

    95.16%

  • Levered Free Cash Flow (ttm)

    163.25M

Research Analysis: SGRY

View More

Company Insights: SGRY

Research Reports: SGRY

View More

People Also Watch